MGX logo

Metagenomi (MGX) Company Overview

Profile

Full Name:

Metagenomi, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

April 6, 2006

Indexes:

Not included

Description:

MGX (Metagenomi) focuses on gene editing technologies to develop innovative therapies for genetic diseases. The company uses advanced tools to modify genes, aiming to improve health outcomes and create new treatment options. Their work combines biotechnology and medicine to address unmet medical needs.

Events Calendar

Earnings

Next earnings date:

Feb 28, 2025

Recent quarterly earnings:

Nov 13, 2024

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Dec 10, 24 HC Wainwright & Co.
Buy
Nov 21, 24 HC Wainwright & Co.
Buy
Nov 20, 24 Chardan Capital
Buy
Oct 15, 24 HC Wainwright & Co.
Buy
Sep 6, 24 HC Wainwright & Co.
Buy
Sep 5, 24 Chardan Capital
Buy
Aug 21, 24 HC Wainwright & Co.
Buy
Aug 19, 24 Chardan Capital
Buy
Aug 15, 24 BMO Capital
Outperform
Jul 15, 24 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

Metagenomi Announces New Appointment to its Board of Directors
Metagenomi Announces New Appointment to its Board of Directors
Metagenomi Announces New Appointment to its Board of Directors
MGX
globenewswire.comJanuary 15, 2025

EMERYVILLE, Calif., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary gene editing toolbox, today announced that Eric Bjerkholt, MBA, CFO of Mirum Pharmaceuticals, Inc., will join Metagenomi's Board of Directors, serving on Metagenomi's Audit and Compensation committees, effective January 27, 2025.

Metagenomi, Inc. Class Action: Levi & Korsinsky Reminds Metagenomi Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 25, 2024 - MGX
Metagenomi, Inc. Class Action: Levi & Korsinsky Reminds Metagenomi Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 25, 2024 - MGX
Metagenomi, Inc. Class Action: Levi & Korsinsky Reminds Metagenomi Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 25, 2024 - MGX
MGX
accesswire.comNovember 25, 2024

NEW YORK, NY / ACCESSWIRE / November 25, 2024 / If you suffered a loss on your Metagenomi, Inc. (NASDAQ:MGX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/metagenomi-lawsuit-submission-form?prid=113560&wire=1 or contact Joseph E. Levi, Esq.

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Metagenomi, Inc. (MGX) Shareholders
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Metagenomi, Inc. (MGX) Shareholders
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Metagenomi, Inc. (MGX) Shareholders
MGX
accesswire.comNovember 25, 2024

NEW YORK, NY / ACCESSWIRE / November 25, 2024 / If you suffered a loss on your Metagenomi, Inc. (NASDAQ:MGX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/metagenomi-lawsuit-submission-form?prid=113547&wire=1 or contact Joseph E. Levi, Esq.

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Metagenomi, Inc. - MGX
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Metagenomi, Inc. - MGX
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Metagenomi, Inc. - MGX
MGX
prnewswire.comNovember 25, 2024

NEW YORK , Nov. 25, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Metagenomi, Inc. ("Metagenomi" or the "Company") (NASDAQ: MGX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

MGX LAWSUIT ALERT: Levi & Korsinsky Notifies Metagenomi, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
MGX LAWSUIT ALERT: Levi & Korsinsky Notifies Metagenomi, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
MGX LAWSUIT ALERT: Levi & Korsinsky Notifies Metagenomi, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
MGX
accesswire.comNovember 25, 2024

NEW YORK, NY / ACCESSWIRE / November 25, 2024 / If you suffered a loss on your Metagenomi, Inc. (NASDAQ:MGX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/metagenomi-lawsuit-submission-form?prid=113528&wire=1 or contact Joseph E. Levi, Esq.

Metagenomi, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before November 25, 2024 to Discuss Your Rights - MGX
Metagenomi, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before November 25, 2024 to Discuss Your Rights - MGX
Metagenomi, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before November 25, 2024 to Discuss Your Rights - MGX
MGX
accesswire.comNovember 25, 2024

NEW YORK, NY / ACCESSWIRE / November 25, 2024 / If you suffered a loss on your Metagenomi, Inc. (NASDAQ:MGX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/metagenomi-lawsuit-submission-form?prid=113509&wire=1 or contact Joseph E. Levi, Esq.

Metagenomi, Inc. Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Urged To Contact The Schall Law Firm
Metagenomi, Inc. Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Urged To Contact The Schall Law Firm
Metagenomi, Inc. Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Urged To Contact The Schall Law Firm
MGX
accesswire.comNovember 25, 2024

LOS ANGELES, CA / ACCESSWIRE / November 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Metagenomi, Inc. ("Metagenomi" or "the Company") (NASDAQ:MGX) for violations of the federal securities laws. Investors who purchased the Company's securities pursuant and/or traceable to the Company's Offering Documents in connection with its initial public offering ("IPO") conducted on or about February 9, 2024, are encouraged to contact the firm before November 25, 2024.

MGX DEADLINE TODAY: ROSEN, A TOP RANKED LAW FIRM, Encourages Metagenomi, Inc. Investors to Secure Counsel Before Important November 25 Deadline in Securities Class Action – MGX
MGX DEADLINE TODAY: ROSEN, A TOP RANKED LAW FIRM, Encourages Metagenomi, Inc. Investors to Secure Counsel Before Important November 25 Deadline in Securities Class Action – MGX
MGX DEADLINE TODAY: ROSEN, A TOP RANKED LAW FIRM, Encourages Metagenomi, Inc. Investors to Secure Counsel Before Important November 25 Deadline in Securities Class Action – MGX
MGX
globenewswire.comNovember 25, 2024

NEW YORK, Nov. 25, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of stock of Metagenomi, Inc. (NASDAQ: MGX) pursuant and/or traceable to the Company's initial public offering conducted between February 9 and 13, 2024 (the “IPO”), of the important November 25, 2024 lead plaintiff deadline.

Metagenomi, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - MGX
Metagenomi, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - MGX
Metagenomi, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - MGX
MGX
accesswire.comNovember 25, 2024

NEW YORK, NY / ACCESSWIRE / November 25, 2024 / If you suffered a loss on your Metagenomi, Inc. (NASDAQ:MGX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/metagenomi-lawsuit-submission-form?prid=113468&wire=1 or contact Joseph E. Levi, Esq.

Shareholders that lost money on Metagenomi, Inc.(MGX) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
Shareholders that lost money on Metagenomi, Inc.(MGX) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
Shareholders that lost money on Metagenomi, Inc.(MGX) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
MGX
accesswire.comNovember 24, 2024

NEW YORK, NY / ACCESSWIRE / November 24, 2024 / If you suffered a loss on your Metagenomi, Inc. (NASDAQ:MGX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/metagenomi-lawsuit-submission-form?prid=113336&wire=1 or contact Joseph E. Levi, Esq.

FAQ

  • What is the ticker symbol for Metagenomi?
  • Does Metagenomi pay dividends?
  • What sector is Metagenomi in?
  • What industry is Metagenomi in?
  • What country is Metagenomi based in?
  • When did Metagenomi go public?
  • Is Metagenomi in the S&P 500?
  • Is Metagenomi in the NASDAQ 100?
  • Is Metagenomi in the Dow Jones?
  • When was Metagenomi's last earnings report?
  • When does Metagenomi report earnings?
  • Should I buy Metagenomi stock now?

What is the ticker symbol for Metagenomi?

The ticker symbol for Metagenomi is NASDAQ:MGX

Does Metagenomi pay dividends?

No, Metagenomi does not pay dividends

What sector is Metagenomi in?

Metagenomi is in the Healthcare sector

What industry is Metagenomi in?

Metagenomi is in the Biotechnology industry

What country is Metagenomi based in?

Metagenomi is headquartered in United States

When did Metagenomi go public?

Metagenomi's initial public offering (IPO) was on April 6, 2006

Is Metagenomi in the S&P 500?

No, Metagenomi is not included in the S&P 500 index

Is Metagenomi in the NASDAQ 100?

No, Metagenomi is not included in the NASDAQ 100 index

Is Metagenomi in the Dow Jones?

No, Metagenomi is not included in the Dow Jones index

When was Metagenomi's last earnings report?

Metagenomi's most recent earnings report was on Nov 13, 2024

When does Metagenomi report earnings?

The next expected earnings date for Metagenomi is Feb 28, 2025

Should I buy Metagenomi stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions